1. World Health Organization (WHO). Report Of The SAGE Working Group On Vaccine Hesitancy [Internet]. 2014 [cited 2020 Jan 13]. Available from: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf
2. World Health Organization (WHO). Ten threats to global health in 2019 [Internet]. 2019 [cited 2019 Sep 3]. Available from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
3. Deml MJ, Dietrich LG, Wingeier B, Etter G, Gallmann C, Berger C, et al. Collaborating with Complementary and Alternative Medicine (CAM) Providers When Writing HPV Vaccine Review Articles. Journal of Clinical Medicine. 2020 Feb 21;9(2):592. DOI: 10.3390/jcm9020592
4. Deml MJ, Jafflin K, Merten S, Huber B, Buhl A, Frau E, et al. Determinants of vaccine hesitancy in Switzerland: study protocol of a mixed-methods national research programme. BMJ Open. 2019 Nov;9(11):e032218. DOI: 10.1136/bmjopen-2019-032218
5. Deml M, Burton-Jeangros C, Notter J, Tarr P. Qu’en-est-il de l’hésitation vaccinale en Suisse? Sage-femme.ch [Internet]. 2018 May [cited 2020 May 13]. Available from: https://archive-ouverte.unige.ch/unige:149155
6. Deml MJ, Mettraux V, Huber B, Krüerke D, Wingeier B, Gallmann C. Impfskepsis in der Schweiz – ein nationales Forschungsprogramm. Praxis Depesche [Internet]. 2018 Dec 1 [cited 2019 Oct 15]. Available from: https://www.researchgate.net/publication/331864509
7. Poland CM, Brunson EK. The need for a multi-disciplinary perspective on vaccine hesitancy and acceptance. Vaccine. 2015 Jan;33(2):277–9. DOI: 10.1016/j.vaccine.2014.11.022
8. Dietrich L, Notter J, Huber B, Wallnöfer A, Huang D, Wingeier B, et al. HPV-Impfung: Update 2019 für die Impfberatung. Swiss Medical Forum. 2019 Mar 27;19(1314):220–6. DOI: 10.4414/smf.2019.08064
9. Wolff E. Über das Impfen. Schweizerische Ärztezeitung. 2019;100(25):868. DOI: https://doi.org/10.4414/saez.2019.17882
10. Lucas Ramanathan P, Baldesberger N, Deml MJ, Dietrich LG, Lüthy A, Buhl A, et al. Health care professionals’ needs around vaccination in Switzerland: A quantitative needs assessment survey. Manuskript eingereicht.
11. Zimmermann C, Schmid Thurneysen L, Deml MJ, Huber BM, Tarr P. Impfskepsis - eine Einführung. Primary and Hospital Care. 2021; Manuskript eingereicht.
12. Tarr PE, Deml MJ, Huber BM. Measles in Switzerland – progress made, but communication challenges lie ahead. Swiss Medical Weekly. 2019 Jun 11;149:w20105. DOI: 10.4414/smw.2019.20105
13. Deml MJ, Buhl A, Notter J, Kliem P, Huber BM, Pfeiffer C, et al. ‘Problem patients and physicians’ failures’: What it means for doctors to counsel vaccine hesitant patients in Switzerland. Social Science & Medicine. 2020 Jun;255:112946. DOI: 10.1016/j.socscimed.2020.112946
14. Schweizerische Akademie der Medizinischen Wissenschaften / Nationale Ethikkommission im Bereich der Humanmedizin (2020). Autonomie in der Medizin: 7 Thesen. Swiss Academies Communications [Internet]. 2020 Nov 5 [cited 2021 Apr 11];15(11). Available from: https://zenodo.org/record/4009253
15. Wellcome Global Monitor. How does the world feel about science and health? [Internet]. wellcome.org. 2019 [cited 2021 Jun 13]. Available from: https://wellcome.org/reports/wellcome-global-monitor/2018
16. Comparis. Medienmitteilung. Repräsentative Comparis-Umfrage zum Impfen. Impfgegner und schlecht Informierte torpedieren Immunitätsschutz gegen lebensgefährliche Krankheiten [Internet]. comparis.ch. 2019 [cited 2020 Nov 5]. Available from: https://www.comparis.ch/comparis/press/medienmitteilungen/artikel/2019/krankenkasse/impfung-umfrage/impfen
17. Wiget Y. Schweizer gehören zu den grössten Impfgegnern weltweit [Internet]. Tages-Anzeiger. 2019 [cited 2021 Jun 13]. Available from: https://www.tagesanzeiger.ch/wissen/medizin-und-psychologie/schweizer-gehoeren-zu-den-groessten-impfgegnern-weltweit/story/24715518
18. Leask J. Target the fence-sitters. Nature. 2011 May;473(7348):443–5. DOI: 10.1038/473443a
19. Bondolfi S. Impfskepsis ist ein Wohlstandsphänomen. Manche Eltern in der Schweiz lassen ihre Kinder bewusst nicht impfen und verhindern damit das Ausrotten von Krankheiten. Welche Motive treiben sie dazu? [Internet]. swissinfo.ch. 2019 [cited 2021 Apr 13]. Available from: https://www.swissinfo.ch/ger/gesundheit_impfskepsis-ist-ein-wohlstandsphaenomen/44852248
20. Impfen? Nein, danke [Internet]. impfen-nein-danke.de. 2020 [cited 2020 May 12]. Available from: https://impfen-nein-danke.de/
21. Brühlmann K. Das hier ist der Final Countdown [Internet]. Tages-Anzeiger. 2020 [cited 2021 Jun 13]. Available from: https://www.tagesanzeiger.ch/the-final-countdown-oder-das-juengste-geruecht-408423572560
22. Deml MJ, Notter J, Kliem P, Buhl A, Huber BM, Pfeiffer C, et al. “We treat humans, not herds!”: A qualitative study of complementary and alternative medicine (CAM) providers’ individualized approaches to vaccination in Switzerland. Social Science & Medicine. 2019 Nov;240:112556. DOI: 10.1016/j.socscimed.2019.112556
23. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin DEGAM. DEGAM-Positionspapier zur Impfpflicht [Internet]. 2019 [cited 2019 Oct 15]. Available from: https://www.degam.de/files/Inhalte/Degam-Inhalte/Ueber_uns/Positionspapiere/DEGAM_Positionspapier_Impfpflicht_final.pdf
24. Klein SD, Torchetti L, Frei-Erb M, Wolf U. Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007. Lafrenie RM, editor. PLoS ONE. 2015 Oct 29;10(10):e0141985. DOI: 10.1371/journal.pone.0141985
25. Wolf U, Maxion-Bergemann S, Bornhöft G, Mathiessen PF, Wolf M. Use of Complementary Medicine in Switzerland. Forschende Komplementärmedizin (2006). 2006 Jun 26;13(2):4–6. DOI: 10.1159/000093488
26. Simoes-Wüst P, Rist L, Dettling M. Self-Reported Health Characteristics and Medication Consumption by CAM Users and Nonusers: A Swiss Cross-Sectional Survey. The Journal of Alternative and Complementary Medicine. 2014 Jan 23;20(1):40–7. DOI: 10.1089/acm.2012.0762
27. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy: An overview. Human Vaccines & Immunotherapeutics. 2013 Aug 8;9(8):1763–73. DOI: 10.4161/hv.24657
28. Wardle J, Frawley J, Steel A, Sullivan E. Complementary medicine and childhood immunisation: A critical review. Vaccine. 2016 Aug;34(38):4484–500. DOI: 10.1016/j.vaccine.2016.07.026
29. Zuzak TJ, Zuzak-Siegrist I, Rist L, Staubli G, Simões-Wüst AP. Attitudes towards vaccination: users of complementary and alternative medicine versus non-users. Swiss Medical Weekly. 2008;138(47–48):713–8. DOI: 10.4414/smw.2008.12423
30. Vereinigung anthroposophisch orientierter Ärzte in der Schweiz (VAOAS). Stellungnahme der VAOAS zu Impfungen [Internet]. 2019 [cited 2020 Apr 27]. Available from: https://vaoas.ch/news/stellungnahme-der-vaoas-zu-impfungen/
31. Schweizerischer Verein Homöopathischer Ärztinnen und Ärzte. Stellungnahme zu den Impfungen - Schweizerischer Verein homöopathischer Ärztinnen und Ärzte (SVHA). 2019 May 2 [cited 2020 Jan 10]; Available from: http://www.svha.ch/uploaded/files/Stellungnahme_Impfungen_2019.pdf
32. International Federation of Anthroposophic Medical Associations (IVAA). Anthroposophic Medicine Statement on Vaccination [Internet]. 2019 [cited 2020 Apr 27]. Available from: https://www.ivaa.info/fileadmin/user_upload/pdf/brochures_and_books/Vaccine_Statement_Med_Section___IVAA_15April2019.pdf
33. Attwell K, Ward PR, Meyer SB, Rokkas PJ, Leask J. “Do-it-yourself”: Vaccine rejection and complementary and alternative medicine (CAM). Social Science & Medicine. 2018 Jan;196:106–14. DOI: 10.1016/j.socscimed.2017.11.022
34. Jafflin K, Deml M, Schwendener C. Manuskript in Vorbereitung.
35. Hornsey MJ, Lobera J, Díaz-Catalán C. Vaccine hesitancy is strongly associated with distrust of conventional medicine, and only weakly associated with trust in alternative medicine. Social Science & Medicine. 2020 Jun;255:113019. DOI: 10.1016/j.socscimed.2020.113019
36. Sirois FM, Riess H, Upchurch DM. Implicit Reasons for Disclosure of the Use of Complementary Health Approaches (CHA): a Consumer Commitment Perspective. Annals of Behavioral Medicine. 2017 Oct;51(5):764–74. DOI: 10.1007/s12160-017-9900-6
37. Salmon DA, Pan WKY, Omer SB, Navar AM, Orenstein W, Marcuse EK, et al. Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children. Human Vaccines. 2008 Jul;4(4):286–91. DOI: 10.4161/hv.4.4.5752
38. Peretti-Watel P, Ward JK, Schulz WS, Verger P, Larson HJ. Vaccine Hesitancy: Clarifying a Theoretical Framework for an Ambiguous Notion. PLoS Currents [Internet]. 2015 [cited 2020 May 28]; Available from: https://currents.plos.org/outbreaks/article/vaccine-hesitancy-clarifying-a-theoretical-framework-for-an-ambiguous-notion/
39. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2012 Jan;12(1):36–44. DOI: 10.1016/S1473-3099(11)70295-X
40. Osterholm MT, Kelley NS, Manske JM, Ballering KS, Leighton TR, Moore KA. The Compelling Need for Game-Changing Influenza Vaccines. An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future. Center of Infectious Disease Research & Policy. University of Minnesota [Internet]. 2012 Oct [cited 2020 May 25]. Available from: https://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines
41. Dietrich L, Abreu De Azevedo M, Wirz S, Deml MJ, Schmid Thurneysen L, Fröhlich J, et al. Infektionen in der Praxis – Update für die Grippesaison 2020/2021. Grippeimpfung: Kritische Beurteilung und praktische Empfehlungen. Primary and Hospital Care. 2021 Feb 3;21(02):52–9. DOI: 10.4414/phc-d.2021.10341
42. Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis. Journal of Infectious Diseases. 2016;213(9):1444–54. DOI: 10.1093/infdis/jiy103
43. Bundesamt für Gesundheit BAG. FAQ Saisonale Grippe (Influenza) [Internet]. 2022 [cited 2022 Jan 23]. Available from:
https://www.infovac.ch/docs/public/influenza/faq-saisonale-grippe-de.pdf
44. Demicheli V, Jefferson T, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults (Review). Primary Health Care [Internet]. 2018 Feb 1 [cited 2020 Feb 17]; Available from: http://journals.rcni.com/doi/10.7748/phc.18.8.31.s24
45. Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews [Internet]. 2018 Feb 1 [cited 2020 Feb 17]; Available from: http://doi.wiley.com/10.1002/14651858.CD004876.pub4
46. Centers for Disease Control and Prevention (CDC). Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017–18 Influenza Season. MMWR Morbidity and Mortality Weekly Report [Internet]. 2017 Aug 25 [cited 2020 Aug 23]. Available from: https://www.cdc.gov/mmwr/volumes/66/rr/rr6602a1.htm
47. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children (Review). Cochrane Database of Systematic Reviews [Internet]. 2018 Feb 1 [cited 2020 Aug 20]; Available from: http://journals.rcni.com/doi/10.7748/phc.18.8.31.s23
48. Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults. New England Journal of Medicine. 2015 Mar 19;372(12):1114–25. DOI: 10.1056/NEJMoa1408544
49. McLaughlin JM, Jiang Q, Isturiz RE, Sings HL, Swerdlow DL, Gessner BD, et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design. Clinical Infectious Diseases. 2018 May 21;67(10):1498–506. DOI: 10.1093/cid/ciy312
50. McLaughlin JM, Swerdlow DL, Isturiz RE, Jodar L. Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications. Vaccine. 2017 Aug 31;35:5360–5. DOI: 10.1016/j.vaccine.2017.08.028
51. Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019 May;74:473–82. DOI: 10.1136/thoraxjnl-2018-211767
52. Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Effect of Age on the Manifestations and Outcomes of Invasive Pneumococcal Disease in Adults. The American Journal of Medicine. 2018 Jan 1;131(1):100.e1-100.e7. DOI: 10.1016/j.amjmed.2017.06.039
53. Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine. 2015 Nov 27;33(4):D60–5. DOI: 10.1016/j.vaccine.2015.05.102
54. Esposito S, Principi N. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children. Journal of Immunology Research. 2015;2015:1–6. DOI: 10.1155/2015/591580
55. Eskola J, Kilpi T, Palmu A, Jokinen J, Eerola M, Haapakoski J, et al. Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media. New England Journal of Medicine. 2001 Feb 8;344(6):403–9. DOI: 10.1056/NEJM200102083440602
56. Peltola H, Booy R, Schmitt H-J. What can children gain from pneumococcal conjugate vaccines? European Journal of Pediatrics. 2004 Sep;163(9):509–16. DOI: 10.1007/s00431-004-1430-0
57. Bundesamt für Gesundheit BAG. Schweizerischer Impfplan 2021 [Internet]. 2021 [cited 2021 Jun 13]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/allgemeine-empfehlungen/schweizerischer-impfplan.pdf.download.pdf/schweizerischer-impfplan-de.pdf
58. Puhan D, Huber F, Solèr R. Medix. Factsheet. Impfungen 2020. Praktische Hinweise zum Schweizerischen Impfplan 2020 [Internet]. medix.ch. 2020 [cited 2021 Jun 13]. Available from: https://www.medix.ch/wissen/guidelines/factsheets/impfungen-2020.html
59. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. European Journal of Epidemiology. 2020 Aug;35(8):775–9. DOI: 10.1007/s10654-020-00671-y
60. Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications. 2021 Jan 4;12(29):1–29. DOI: 10.1038/s41467-020-20226-9
61. Britton A, Slifka KMJ, Edens C, Nanduri SA, Bart SM, Shang N, et al. Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021. MMWR Morbidity and Mortality Weekly Report. 2021 Mar 19;70(11):396–401. DOI: http://dx.doi.org/10.15585/mmwr.mm7011e3
62. Thompson MG, Burgess JL, Naleway AL, Tyner HL, Yoon SK, Meece J, et al. Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021. MMWR Morbidity and Mortality Weekly Report. 2021 Apr 2;70(13):495–500. DOI: http://dx.doi.org/10.15585/mmwr.mm7013e3
63. Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 Vaccination Program. JAMA. 2020 Jun 23;323(24):2458–9. DOI: 10.1001/jama.2020.8711
64. Schwartz JL. Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust. New England Journal of Medicine. 2020 Oct 29;383(18):1703–5. DOI: 10.1056/NEJMp2026393
65. Rubin EJ, Harrington DP, Hogan JW, Gatsonis C, Baden LR, Hamel MB. The Urgency of Care during the Covid-19 Pandemic — Learning as We Go. New England Journal of Medicine. 2020 Jun 18;382(25):2461–2. DOI: 10.1056/NEJMe2015903
66. Callaway E. The Race for Coronavirus Vaccines. Nature [Internet]. 2020 Apr 28 [cited 2021 Apr 27]. Available from: https://www.nature.com/articles/d41586-020-01221-y
67. Russonello G. The Rising Politicization of Covid Vaccines. The New York Times [Internet]. 2021 Apr 8 [cited 2021 Apr 27]; Available from: https://www.nytimes.com/2021/04/06/us/politics/covid-vaccine-skepticism.html
68. The COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet Infectious Diseases. 2020 May;20(7):769–70. DOI: 10.1016/S1473-3099(20)30426-6
69. Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. New England Journal of Medicine. 2021 Aug 12;385(7):661–2. DOI: 10.1056/NEJMc2108861
70. Hall VG, Ferreira VH, Ku T, Ierullo M, Majchrzak-Kita B, Chaparro C, et al. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients. New England Journal of Medicine [Internet]. 2021 Aug 11 [cited 2021 Sep 21]; Available from: http://www.nejm.org/doi/10.1056/NEJMc2111462
71. Aslam S, Adler E, Mekeel K, Little SJ. Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients. Transplant Infectious Disease. 2021 Aug 3;e13705. DOI: 10.1111/tid.13705
72. Doria-Rose N, Suthar MS, Makowski M, O’Connell S, McDermott AB, Flach B, et al. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. New England Journal of Medicine. 2021 Jun 10;2259–61. DOI: 10.1056/NEJMc2103916
73. Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, Elbaz M, Nesher L, Stein M, et al. BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection [Internet]. 2021 [cited 2021 Sep 21]; Available from: https://doi.org/10.1016/j.cmi.2021.06.036
74. Grannis SJ, Rowley EA, Ong TC, Stenehjem E, Klein NP, DeSilva MB, et al. Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021. MMWR Morbidity and Mortality Weekly Report [Internet]. 2021 Sep 10 [cited 2021 Sep 21];70. Available from: http://www.cdc.gov/mmwr/volumes/70/wr/mm7037e2.htm?s_cid=mm7037e2_w
75. Bajema KL, Dahl RM, Prill MM, Meites E, Rodriguez-Barradas MC, Marconi VC, et al. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021. MMWR Morbidity and Mortality Weekly Report [Internet]. 2021 Sep 10 [cited 2021 Sep 21];70. Available from: http://www.cdc.gov/mmwr/volumes/70/wr/mm7037e3.htm?s_cid=mm7037e3_w
76. Nanduri S, Pilishvili T, Derado G, Soe MM, Dollard P, Wu H, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021. MMWR Morbidity and Mortality Weekly Report. 2021 Aug 27;70(34):1163–6. DOI: 10.15585/mmwr.mm7034e3
77. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. The Lancet [Internet]. 2021 Sep 13 [cited 2021 Sep 21]; Available from: https://doi.org/10.1016/S0140-6736(21)02046-8
78. Tenforde MW, Self WH, Naioti EA, Ginde AA, Douin DJ, Olson SM, et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1156–62. DOI: 10.15585/mmwr.mm7034e2
79. World Health Organization (WHO). DRAFT landscape of COVID-19 candidate vaccines [Internet]. who.int. 2020 [cited 2021 Apr 27]. Available from: https://www.who.int/blueprint/priority-diseases/key-action/Novel_Coronavirus_Landscape_nCoV_11April2020.PDF
80. Wood S, Schulman K. Beyond Politics — Promoting Covid-19 Vaccination in the United States. Malina D, editor. New England Journal of Medicine. 2021 Feb 18;384(7):e23. DOI: 10.1056/NEJMms2033790
81. Kounis NG, Koniari I, de Gregorio C, Velissaris D, Petalas K, Brinia A, et al. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations. Vaccines. 2021 Mar 5;9:221. DOI: 10.3390/vaccines9030221
82. Blumenthal KG, Robinson LB, Camargo Jr CA, Shenoy ES, Banerji A, Landman AB, et al. Acute Allergic Reactions to mRNA COVID-19 Vaccines. JAMA. 2021 Apr 20;325(15):1562–5. DOI: 10.1001/jama.2021.3976
83. Warren CM, Snow TT, Lee AS, Shah MM, Heider A, Blomkalns A, et al. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open. 2021 Sep 17;4(9):e2125524. DOI: 10.1001/jamanetworkopen.2021.25524
84. Krantz MS, Kwah JH, Stone CA, Phillips EJ, Ortega G, Banerji A, et al. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Internal Medicine [Internet]. 2021 Jul 26 [cited 2021 Sep 21]; Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2782348
85. Centers for Disease Control and Prevention (CDC). Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination [Internet]. 2021 [cited 2021 Jun 26]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
86. Shimabukuro T. Vaccines and Related Biological Products Advisory Committee June 10, 2021 Meeting Presentation [Internet]. 2021 [cited 2021 Jun 26]. Available from: https://www.fda.gov/media/150054/download
87. Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Sep 3;10. DOI: 10.1001/jama.2021.15072
88. Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine. 2021 Aug 25;385(12):1078–90. DOI: 10.1056/NEJMoa2110475
89. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv [Preprint]. 2021 Jul 27;2021.07.23.21260998. DOI: 10.1101/2021.07.23.21260998
90. ExpertInnenrat der Bundesregierung zu COVID-19. 5. Stellungnahme des ExpertInnenrates der Bundesregierung zu COVID-19. Zur Notwendigkeit evidenzbasierter Risiko- und Gesundheitskommunikation. 30.1.2022. https://www.bundesregierung.de/resource/blob/997532/2002168/ea5301f932dafa791129440858746e0a/2022-01-30-fuenfte-stellungnahme-expertenrat-data.pdf
91. Wallace DM, Oliver DS. COVID-19 mRNA vaccines in adolescents and young adults: Benefit-risk discussion. ACIP Meeting. CDC [Internet]. 2021 Jun 23 [cited 2021 Sep 21]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-COVID-Wallace-508.pdf
92. World Health Organization (WHO). Director-General’s opening remarks at the media briefing on COVID-19 – 14 May 2021 [Internet]. 2021 [cited 2021 Jun 13]. Available from: https://www.who.int/director-general/speeches/detail/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-14-may-2021
93. Bundesärztekammer. Mehr Daten für Empfehlung zu Impfungen von Kindern erforderlich [Internet]. bundesaerztekammer.de. 2021 [cited 2021 Jun 13]. Available from: https://www.bundesaerztekammer.de/presse/pressemitteilungen/news-detail/mehr-daten-fuer-empfehlung-zu-impfungen-von-kindern-erforderlich/
94. Lühmann D, Meyer G. Deutsches Netzwerk Evidenz-basierte Medizin e.V. (EbM-Netzwerk). Impfung von Kindern und Jugendlichen gegen SARS-CoV-2 verlangt einen sorgfältigen öffentlichen Diskurs [Internet]. ebm-netzwerk.de. 2021 [cited 2021 Jun 13]. Available from: https://www.ebm-netzwerk.de/de/veroeffentlichungen/nachrichten/stellungnahme-impfung-kinder-jugendliche
95. aerzteblatt.de. STIKO-Vorsitzender verteidigt vorsichtige Haltung zu Coronaimpfungen bei Kindern [Internet]. aerzteblatt.de. 2021 [cited 2021 Jun 13]. Available from: https://www.aerzteblatt.de/nachrichten/124306/STIKO-Vorsitzender-verteidigt-vorsichtige-Haltung-zu-Coronaimpfungen-bei-Kindern
96. Deutsche Welle (DW). COVID vaccines: Give doses to COVAX not kids, WHO urges [Internet]. dw.com. 2021 [cited 2021 Jun 13]. Available from: https://www.dw.com/en/covid-vaccines-give-doses-to-covax-not-kids-who-urges/a-57466344
97. Wingeier B, Avoledo P, Schmid Thurneysen L, Zimmermann C, Schwendener C, Kiener L, et al. Sollen wir Kinder und Jugendliche gegen Covid-19 impfen? Primary and Hospital Care. 2021 Jul 7;21(07):223–5. DOI: https://doi.org/10.4414/phc-d.2021.10428
98. Bundesamt für Gesundheit (BAG) und Eidgenössische Kommission für Impffragen (EKIF). Impfempfehlung für mRNA-Impfstoffe gegen Covid-19 (Stand 21.01.22) [Internet]. bag.admin.ch. 2022 [cited 2022 Jan 23]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/k-und-i/aktuelle-ausbrueche-pandemien/2019-nCoV/impfempfehlung-covid-19.pdf.download.pdf/Impfempfehlung%20f%C3%BCr%20mRNA-Impfstoffe%20gegen%20Covid-19.pdf
99. Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021 Apr 9;1–7. DOI: 10.1056/NEJMoa2104882
100. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 2021 Apr 9;1–10. DOI: 10.1056/NEJMoa2104840
101. Muir K-L, Kallam A, Koepsell SA, Gundabolu K. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination. New England Journal of Medicine. 2021 Apr 14;1–2. DOI: 10.1056/NEJMc2105869
102. Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021 Apr 16;1–10. DOI: 10.1056/NEJMoa2105385
103. European Medicines Agency. AstraZeneca’s COVID-19 vaccine: benefits and risks in context [Internet]. ema.europa.eu. 2021 [cited 2021 Apr 29]. Available from: https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-benefits-risks-context
104. Oliver S. Advisory Committee on Immunization Practices (ACIP). Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines [Internet]. Coronavirus Disease 2019 (COVID-19) Vaccines; 2021 Apr 23 [cited 2021 Jun 2]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-04-23/06-COVID-Oliver-508.pdf
106. Spaar A, Heininger U, Stronski Huwiler S, Masserey Spicher V. Die HPV-Impfung ist wirksam und sicher. BAG Bulletin [Internet]. 2018 Jan 15 [cited 2019 Nov 29]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/hpv/hpv-impfung-wirksam-sicher.pdf
107. Spaar A, Heininger U, Stronski Huwiler S, Masserey Spicher V. Die HPV-Impfung ist wirksam und sicher. Aktueller Stand zur Wirksamkeit und Sicherheit der verfügbaren Impstoffe. Ars Medici [Internet]. 2017 Dec [cited 2020 Jul 16]. Available from:
https://www.rosenfluh.ch/arsmedici-2017-24/die-hpv-impfung-ist-wirksam-und-sicher
108. Bundesamt für Gesundheit BAG. Nationale Strategie zur Prävention der saisonalen Grippe (GRIPS) 2015-2018 (weiterhin gültig bis Ende 2020). [Internet]. 2014 [cited 2020 Aug 8]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-i/grips/strategie-grips.pdf.download.pdf/Strategie%20GRIPS.pdf
109. INFOVAC. Grippe (Influenza) [Internet]. 2020 [cited 2020 Aug 8]. Available from: https://www.infovac.ch/de/impfunge/nach-krankheiten-geordnet/grippe
110. Bundesamt für Gesundheit BAG. Nebenwirkungen, Mythen & Fragen [Internet]. bag-coronavirus.ch. 2021 [cited 2021 Apr 24]. Available from: https://bag-coronavirus.ch/impfung/nebenwirkungen-fragen/
111. INFOVAC. Hauptargumente für eine Impfung [Internet]. Infovac.ch. 2020 [cited 2020 May 12]. Available from: https://www.infovac.ch/de/faq/wieso-impfen
112. Dubé E, Gagnon D, MacDonald NE, the SAGE Working Group on Vaccine Hesitancy. Strategies intended to address vaccine hesitancy: Review of published reviews. Vaccine. 2015 Aug 14;33(34):4191–203. DOI: 10.1016/j.vaccine.2015.04.041
113. Ebi S, Deml MJ, Jafflin K, Buhl A, Engel R, Picker J, et al. “We have so much information that we can get lost in it”: A Mixed-Methods Study on Parents’ Vaccination Information Seeking, Satisfaction with, and Trust in Medical Providers in Switzerland. 2021; Manuskript eingereicht.
114. Amit Aharon A, Nehama H, Rishpon S, Baron-Epel O. Parents with high levels of communicative and critical health literacy are less likely to vaccinate their children. Patient Education and Counseling. 2017 Apr;100(4):768–75. DOI: 10.1016/j.pec.2016.11.016
115. Kahan DM. A Risky Science Communication Environment for Vaccines. Science. 2013 Oct 4;342(6154):53–4. DOI: 10.1126/science.1245724
116. Betsch C, Sachse K. Debunking vaccination myths: Strong risk negations can increase perceived vaccination risks. Health Psychology. 2013;32(2):146–55. DOI: 10.1037/a0027387
117. Petersen MB, Bor A, Jørgensen F, Lindholt MF. Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust. Proc Natl Acad Sci USA. 2021 Jul 20;118(29):e2024597118. DOI: 10.1073/pnas.2024597118
118. World Health Organization (WHO). Vaccine hesitancy: A growing challenge for immunization programmes [Internet]. 2015 [cited 2020 Jul 24]. Available from: https://www.who.int/news/item/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes
119. Kahan D. Fixing the communications failure. Nature. 2010 Jan;463(7279):296–7. DOI: 10.1038/463296a
120. Brunson EK. The Impact of Social Networks on Parents’ Vaccination Decisions. Pediatrics. 2013 May 1;131(5):e1397–404. DOI: 10.1542/peds.2012-2452
121. Deml MJ, Ebi S, Jafflin K, Buhl A, Engel R, Picker J, et al. Parents’ Vaccination Information Seeking Behaviors, Satisfaction with, and Trust in Providers in Switzerland. Abstract Jahrestagung 2021 pädiatrie schweiz. 2021 Jun 10.
122. Luman ET, Chu SY. When and Why Children Fall Behind with Vaccinations. American Journal of Preventive Medicine. 2009 Feb 1;36(2):105–11. DOI: https://doi.org/10.1016/j.amepre.2008.09.035
123. Oliveira CR, Rock RM, Shapiro ED, Xu X, Lundsberg L, Zhang LB, et al. Missed opportunities for HPV immunization among young adult women. American Journal of Obstetrics and Gynecology. 2018 Mar;218(3):326.e1-326.e7. DOI: 10.1016/j.ajog.2017.11.602
124. Masserey Spicher V. Facteurs expliquant les différences de couverture entre cantons en Suiss: résultats de l’étude FEVAC réaliséen 2014-2015. Maladies transmissibles [Internet]. OFSP-Bulletin. 2018 [cited 2020 Jul 16]. Available from: https://www.bag.admin.ch/dam/bag/fr/dokumente/cc/Kampagnen/Bulletin/2018/BU_9_18.pdf.download.pdf/BU_9_18_FR.pdf
125. Masserey Spicher V, Weiss MG. Policy and socio-cultural differences between cantons in Switzerland with high and low adolescent vaccination coverage for hepatitis B and HPV. Vaccine. 2019 Dec;37(52):7539–46. DOI: 10.1016/j.vaccine.2019.09.085
126. Bundesamt für Gesundheit BAG. Abteilung Übertragbare Krankheiten. HPV: Antworten auf häufig gestellte Fragen [Internet]. bag.admin.ch. 2016 [cited 2021 Apr 25]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/hpv/hpv-faq.pdf.download.pdf/hpv-faq-de.pdf
127. Bundesamt für Gesundheit (BAG) und Eidgenössische Kommission für Impffragen (EKIF). Pneumokokkenimpfung: Empfehlungen zur Verhinderung von invasiven Pneumokokkenerkrankungen bei Risikogruppen [Internet]. bag.admin.ch. 2014 [cited 2021 Apr 25]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/richtlinien-empfehlungen/empfehlungen-spezifische-erreger-krankheiten/pneumokokken/empfehlung-verhinderung-invasive-pneumokokkenerkrankung-risikogruppen.pdf.download.pdf/bu-8-2014-pneumokokken-risikogruppen.pdf
128. Bieri U, Kocher JP, Gauch C, Tschöpe S, Venetz A, Hagemann M, et al. Bevölkerungsbefragung ‘Erhebung Gesundheitskompetenz 2015’. Schlussbericht. Studie im Auftrag des Bundesamts für Gesundheit BAG, Abteilung Gesundheitsstrategien. Bundesamts für Gesundheit BAG, Abteilung Gesundheitsstrategien, Bern [Internet]. 2016 May 18 [cited 2021 Apr 24]; Available from: https://docplayer.org/25440726-Bevoelkerungsbefragung-erhebung-gesundheitskompetenz.html
129. Kaya B. Compétences en matière de santé. Relation patient – professionnel de santé et accès à l’information relative à la santé. Croix-Rouge suisse: Berne Cette étude a été soutenue par l’Office fédéral de la santé publique OFSP [Internet]. 2018 [cited 2021 Apr 25]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/nat-gesundheitsstrategien/nat-programm-migration-und-gesundheit/gesundheitskompetenz-von-migrantinnen-und-migranten/Comp%C3%A9tences%20en%20mati%C3%A8re%20de%20sant%C3%A9.%20Relation%20patient%20et%20professionnel.pdf.download.pdf/Comp%C3%A9tences%20en%20mati%C3%A8re%20de%20sant%C3%A9.%20Relation%20patient%20et%20professionnel.pdf
130. Lang P, Sinniger P, Spaar A, Born R, Hatz C. Evolution of the HPV vaccination coverage in Switzerland, 2008-2016. Poster, Swiss Public Health Conference, Basel [Internet]. 2017 Nov 22 [cited 2020 Jan 10]. Available from: https://organizers-congress.org/frontend/index.php?page_id=4146&additions_conferenceschedule_action=detail&additions_conferenceschedule_controller=paperList&pid=4441&hash=f49071bb2676ff88f7aec864a67f329c1fde52556e03f405c0b67e1d268c0707
131. Bundesamt für Gesundheit BAG. Durchimpfung von 2-, 8- und 16-Jährigen in der Schweiz, 2011 bis 2013 [Internet]. BAG Bulletin. 2015 [cited 2021 Jun 13]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/durchimpfung/bu-28-15-durchimpfung-2011-2013.pdf.download.pdf/bu-28-15-durchimpfung-2011-13.pdf
132. Bundesamt für Gesundheit BAG. Durchimpfung von 2-, 8- und 16-jährigen Kindern in der Schweiz, 1999-2020 [Internet]. bag.admin.ch. 2021 [cited 2020 Jun 13]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/i-und-b/durchimpfung/tabelle-durchimpfung.xlsx.download.xlsx/bag-tabelle-durchimpfung-2020.xlsx
133. NHS. Who should have the HPV vaccine? [Internet]. www.nhs.uk. 2019 [cited 2020 Jun 13]. Available from: https://www.nhs.uk/conditions/vaccinations/who-should-have-hpv-cervical-cancer-cervarix-gardasil-vaccine/
134. Moss JL, Reiter PL, Rimer BK, Brewer NT. Collaborative patient-provider communication and uptake of adolescent vaccines. Social Science & Medicine. 2016 Jun;159:100–7. DOI: 10.1016/j.socscimed.2016.04.030
135. Webb RAJ. Fear and Communication. Journal of Drug Education. 1974 Mar 1;4(1):97–103. DOI: 10.2190/JQ4F-5GNX-JMEX-G64B
136. Janis IL, Feshbach S. Effects of fear-arousing communications. The Journal of Abnormal and Social Psychology. 1953;48(1):78–92. DOI: 10.1037/h0060732
137. Sauerbrey A. What Comes After Angela Merkel? Germany’s big political parties are imploding, but no one knows what will come next [Internet]. The New York Times. 2019 [cited 2021 Jun 13]. Available from: https://www.nytimes.com/2019/05/31/opinion/angela-merkel-germany.html
138. Ward P. The Guardian. Labelling anti-vaxxers as bad parents doesn’t help – it just leads to more distrust in science [Internet]. 2019 [cited 2020 Apr 27]. Available from: https://www.theguardian.com/commentisfree/2019/may/13/labelling-anti-vaxxers-as-bad-parents-doesnt-help-it-just-leads-to-more-distrust-in-science
139. Schweizer Radio und Fernsehen SRF. Tiefe Durchimpfungsrate. Das Masernvirus hat ein leichtes Spiel [Internet]. SRF Schweizer Radio und Fernsehen. 2019 [cited 2020 May 18]. Available from: https://www.srf.ch/news/schweiz/tiefe-durchimpfungsrate-das-masernvirus-hat-ein-leichtes-spiel
140. Mülhauser I, Sönnichsen A. Deutsches Netzwerk Evidenz-basierte Medizin e.V. (EbM-Netzwerk). Impfpflicht versus informierte Entscheidung: Perspektive der Evidenzbasierten Medizin [Internet]. ebm-netzwerk.de. 2019 [cited 2019 Sep 3]. Available from: https://www.ebm-netzwerk.de/de/veroeffentlichungen/pdf/stn-20190502-impfen.pdf
141. Nyhan B, Reifler J, Richey S, Freed GL. Effective Messages in Vaccine Promotion: A Randomized Trial. Pediatrics. 2014 Apr 1;133(4):835–42. DOI: 10.1542/peds.2013-2365
142. Browne M, Thomson P, Rockloff MJ, Pennycook G. Going against the Herd: Psychological and Cultural Factors Underlying the ‘Vaccination Confidence Gap’. Perales JC, editor. PLoS ONE. 2015 Sep 1;10(9):e0132562. DOI: 10.1371/journal.pone.0132562
143. Masaryk R, Hatoková M. Qualitative inquiry into reasons why vaccination messages fail. Journal of Health Psychology. 2017 Dec;22(14):1880–8. DOI: 10.1177/1359105316656770
144. Bundesamt für Gesundheit BAG. Abteilung übertragbare Krankheiten. Masern: Antworten auf häufig gestellte Fragen (Stand: März 2019) [Internet]. 2020 [cited 2020 Feb 17]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/infektionskrankheiten/masern/masern-faq.pdf.download.pdf/faq-masern-de.pdf
145. World Health Organization (WHO). Immunization, Vaccines and Biologicals - Measles [Internet]. 2020 [cited 2020 May 26]. Available from: https://www.who.int/immunization/diseases/measles/en/
146. World Health Organization (WHO). More than 140,000 die from measles as cases surge worldwide [Internet]. 2019 [cited 2020 May 26]. Available from: https://www.who.int/news-room/detail/05-12-2019-more-than-140-000-die-from-measles-as-cases-surge-worldwide
147. Centers for Disease Control and Prevention (CDC). Vaccines Do Not Cause Autism [Internet]. 2020 [cited 2020 May 12]. Available from: https://www.cdc.gov/vaccinesafety/concerns/autism.html
148. DeStefano F, Price CS, Weintraub ES. Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism. The Journal of Pediatrics. 2013 Aug;163(2):561–7. DOI: 10.1016/j.jpeds.2013.02.001
149. Hviid A, Hansen JV, Frisch M, Melbye M. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. Annals of Internal Medicine. 2019 Apr 16;170(8):513. DOI: 10.7326/M18-2101
150. Spaar VA, Masserey V. HPV-Impfung in der Schweiz. Impfraten und aktuelle Daten zu Wirksamkeit und Sicherheit. Pädiatrie [Internet]. 2015 Dec [cited 2020 Jan 27]. Available from: https://www.rosenfluh.ch/media/paediatrie/2015/06/HPV-Impfung-in-der-Schweiz.pdf
151. Bundesamt für Gesundheit BAG. Jetzt gegen die Grippe impfen – sich und andere schützen [Internet]. bag.admin.ch. 2017 [cited 2021 Apr 25]. Available from: https://www.bag.admin.ch/bag/de/home/das-bag/aktuell/news/news-16-10-2017.html
152. Potasman I, Sabo E, Paz A, Nir Y. Fear of injections in young adults: prevalence and associations. The American Journal of Tropical Medicine and Hygiene. 2003 Mar 1;68(3):341–4. DOI: 10.4269/ajtmh.2003.68.341
153. Hamilton JG. Needle Phobia: A Neglected Diagnosis. PMID: 7636457. 1995 Aug;41(2):169–75. PMID: 7636457
154. Taddio A, Ipp M, Thivakaran S, Jamal A, Parikh C, Smart S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012 Jul 6;30(32):4807–12. DOI: https://doi.org/10.1016/j.vaccine.2012.05.011
155. Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing Vaccination: Putting Psychological Science Into Action. Psychological Science in the Public Interest. 2017 Dec;18(3):149–207. DOI: 10.1177/1529100618760521
156. Bundesamt für Gesundheit (BAG). Informationswebsites des BAG zur saisonalen Grippe und der Grippeimpfung. Schutz vor der Grippe [Internet]. [cited 2021 Jun 3]. Available from: https://www.impfengegengrippe.ch/de-ch/
157. Verband Zürcher Krankenhäuser VZK. Grippeimpfung beim Gesundheitspersonal [Internet]. vzk.ch. [cited 2021 Apr 26]. Available from: https://www.vzk.ch/gesundheitspolitik/dossiers/grippe-impfung
158. Verband Zürcher Krankenhäuser VZK. Grippe-Impfquote beim Gesundheitspersonal deutlich gesteigert [Internet]. vzk.ch. 2021 [cited 2021 Apr 26]. Available from: https://www.vzk.ch/news/grippe-impfquote-deutlich-gesteigert
159. Oehler RL. On Measles, Vaccination, Social Media Activism and How to Win Back Our Role as our Patients’ Best Advocates. Clinical Infectious Diseases. 2019 Jul 15;70(2):338–40. DOI: 10.1093/cid/ciz656
160. Rigos A. Soll ich mein Kind impfen lassen? Das sagen die Fakten [Internet]. GEO WISSEN GESUNDHEIT. 2016 [cited 2021 Jun 13]. Available from: https://www.geo.de/magazine/geo-wissen-gesundheit/188-rtkl-impfung-bei-kindern-soll-ich-mein-kind-impfen-lassen-das
161. Bertram H, Deuflhard C. Die überforderte Generation: Arbeit und Familie in der Wissensgesellschaft [Internet]. 1st ed. Verlag Barbara Budrich; 2014 [cited 2020 Aug 22]. Available from: http://www.jstor.org/stable/10.2307/j.ctvdf06tk
162. Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, et al. Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France. EBioMedicine. 2015 Aug;2(8):891–7. DOI: 10.1016/j.ebiom.2015.06.018
163. Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016 Dec;34(52):6700–6. DOI: 10.1016/j.vaccine.2016.10.042
164. Davis TC, Fredrickson DD, Arnold CL, Cross JT, Humiston SG, Green KW, et al. Childhood Vaccine Risk/Benefit Communication in Private Practice Office Settings: A National Survey. Pediatrics. 2001 Feb 1;107(2):e17–e17. DOI: 10.1542/peds.107.2.e17
165. Lakin JR, Tulsky JA, Bernacki RE. Time Out Before Talking: Communication as a Medical Procedure. Annals of Internal Medicine. 2021 Jan;174(1):96–7. DOI: 10.7326/M20-4223
166. Centers for Disease Control and Prevention (CDC). Ten Great Public Health Achievements - United States, 1900-1999. MMWR Morbidity and Mortality Weekly Report [Internet]. 1999 Jan 4 [cited 2020 Aug 23]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm
167. Jones AM, Omer SB, Bednarczyk RA, Halsey NA, Moulton LH, Salmon DA. Parents’ Source of Vaccine Information and Impact on Vaccine Attitudes, Beliefs, and Nonmedical Exemptions. Advances in Preventive Medicine. 2012 Sep 7;1–8. DOI: 10.1155/2012/932741
168. Wang E, Baras Y, Buttenheim AM. “Everybody just wants to do what’s best for their child”: Understanding how pro-vaccine parents can support a culture of vaccine hesitancy. Vaccine. 2015 Nov;33(48):6703–9. DOI: 10.1016/j.vaccine.2015.10.090
169. Betsch C, Sachse K. Dr. Jekyll or Mr. Hyde? (How) the Internet influences vaccination decisions: Recent evidence and tentative guidelines for online vaccine communication. Vaccine. 2012 May 28;30(25):3723–6. DOI: 10.1016/j.vaccine.2012.03.078
170. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: A critical review. Social Science & Medicine. 2014 Jul;112:1–11. DOI: 10.1016/j.socscimed.2014.04.018
171. Kata A. A postmodern Pandora’s box: Anti-vaccination misinformation on the Internet. Vaccine. 2010 Feb;28(7):1709–16. DOI: 10.1016/j.vaccine.2009.12.022
172. Sobo EJ, Huhn A, Sannwald A, Thurman L. Information Curation among Vaccine Cautious Parents: Web 2.0, Pinterest Thinking, and Pediatric Vaccination Choice. Medical Anthropology. 2016 Nov;35(6):529–46. DOI: 10.1080/01459740.2016.1145219
173. Betsch C, Renkewitz F, Betsch T, Ulshöfer C. The Influence of Vaccine-critical Websites on Perceiving Vaccination Risks. Journal of Health Psychology. 2010 Apr;15(3):446–55. DOI: 10.1177/1359105309353647
174. Davies P. Antivaccination activists on the world wide web. Archives of Disease in Childhood. 2002 Jul 1;87(1):22–5. DOI: 10.1136/adc.87.1.22
175. Johnson NF, Velásquez N, Restrepo NJ, Leahy R, Gabriel N, El Oud S, et al. The online competition between pro- and anti-vaccination views. Nature. 2020 Jun;582(7811):230–3. DOI: 10.1038/s41586-020-2281-1
176. Dubé E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon. Vaccine. 2014 Nov;32(49):6649–54. DOI: 10.1016/j.vaccine.2014.09.039
177. Vrdelja M, Kraigher A, Verčič D, Kropivnik S. The growing vaccine hesitancy: exploring the influence of the internet. European Journal of Public Health. 2018 Oct 1;28(5):934–9. DOI: 10.1093/eurpub/cky114
178. Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Global Health. 2020 Oct;5(10):e004206. DOI: 10.1136/bmjgh-2020-004206
179. Charron J, Gautier A, Jestin C. Influence of information sources on vaccine hesitancy and practicesଝ. Médecine et maladies infectieuses. 2020;7. DOI: 10.1016/j.medmal.2020.01.010
180. Reich JA. “We are fierce, independent thinkers and intelligent”: Social capital and stigma management among mothers who refuse vaccines. Social Science & Medicine. 2018 Oct;257:112015. DOI: 10.1016/j.socscimed.2018.10.027
181. Giambi C, Fabiani M, D’Ancona F, Ferrara L, Fiacchini D, Gallo T, et al. Parental vaccine hesitancy in Italy – Results from a national survey. Vaccine. 2018 Feb;36(6):779–87. DOI: 10.1016/j.vaccine.2017.12.074
182. Barsky AJ. The Paradox of Health. New England Journal of Medicine. 1988 Aug 18;318(7):414–8. DOI: 10.1056/NEJM198802183180705
183. Anderegg S, Huwiler S. Diese Ärzte kassieren am meisten. Heikle Beraterhonorare. Jedes Jahr zahlen Pharmafirmen Millionen an Ärzte und Organisationen. Neue Daten zeigen: Die Topverdiener sind in Zürich. [Internet]. Tages-Anzeiger. 2020 [cited 2021 Jun 13]. Available from: https://www.tagesanzeiger.ch/zuercher-aerzte-erhalten-besonders-viel-pharmageld-655643007898
184. Henrikson NB, Opel DJ, Grothaus L, Nelson J, Scrol A, Dunn J, et al. Physician Communication Training and Parental Vaccine Hesitancy: A Randomized Trial. Pediatrics. 2015 Jul;136(1):70–9. DOI: 10.1542/peds.2014-3199
185. Buhl A, Schmid Thurneysen L, Deml M, Tarr P. Consultation and Communication with Vaccine Hesitant Patients: An Expert Focus Group Discussion Study. Abstract Jahrestagung 2021 pädiatrie schweiz. 2021 Jun 10;
186. Poland GA, Ovsyannikova IG, Kennedy RB. Personalized vaccinology: A review. Vaccine. 2018 Aug;36(36):5350–7. DOI: 10.1016/j.vaccine.2017.07.062
187. Santana M j, Manalili K, Jolley RJ, Zelinsky S, Quan H, Lu M. How to practice person‐centred care: A conceptual framework. Health Expectations. 2018;21(2):429–40. DOI: https://doi.org/10.1111/hex.12640
188. Sharrer GT. Personalized Medicine: Ethical Aspects. Methods in Molecular Biology. 2017;1606:37–50. DOI: 10.1007/978-1-4939-6990-6_3
189. Bedford H, Attwell K, Danchin M, Marshall H, Corben P, Leask J. Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology. Vaccine. 2018 Oct;36(44):6556–8. DOI: 10.1016/j.vaccine.2017.08.004
190. Mangione-Smith R, McGlynn EA, Elliott MN, McDonald L, Franz CE, Kravitz RL. Parent Expectations for Antibiotics, Physician-Parent Communication, and Satisfaction. Archives of Pediatrics & Adolescent Medicine. 2001 Jul;155(7):800–6. DOI: 10.1001/archpedi.155.7.800
191. Streuli JC, Anderson J, Alef-Defoe S, Bergsträsser E, Jucker J, Meyer S, et al. Combining the best interest standard with shared decision-making in paediatrics—introducing the shared optimum approach based on a qualitative study. European Journal of Pediatrics. 2021 Mar;180(3):759–66. DOI: 10.1007/s00431-020-03756-8
192. Rollnick S, Butler CC, Kinnersley P, Gregory J, Mash B. Motivational interviewing. BMJ. 2010 Apr 27;340(apr27 2):c1900–c1900. DOI: 10.1136/bmj.c1900
193. Gagneur A, Gosselin V, Dubé È. Motivational interviewing: A promising tool to address vaccine hesitancy. Vaccine. 2018 Oct;36(44):6553–5. DOI: 10.1016/j.vaccine.2017.10.049
194. Gagneur A, Lemaître T, Gosselin V, Farrands A, Carrier N, Petit G, et al. A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study. BMC Public Health. 2018 Dec;18(1):811. DOI: 10.1186/s12889-018-5724-y
195. Lemaitre T, Carrier N, Farrands A, Gosselin V, Petit G, Gagneur A. Impact of a vaccination promotion intervention using motivational interview techniques on long-term vaccine coverage: the PromoVac strategy. Human Vaccines & Immunotherapeutics. 2019 Mar 4;15(3):732–9. DOI: 10.1080/21645515.2018.1549451
196. Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015 Feb;33(9):1223–9. DOI: 10.1016/j.vaccine.2014.11.021
197. Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, et al. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination. JAMA pediatrics. 2018 May 7;172(5):e180016. DOI: 10.1001/jamapediatrics.2018.0016
198. Shapiro E. Injudicious Antibiotic Use: An Unforeseen Consequence of the Emphasis on Patient Satisfaction? Clinical Therapeutics. 2002 Jan;24(1):197–204. DOI: 10.1016/s0149-2918(02)85015-9
199. Brody DS, Miller SM, Lerman CE, Smith DG, Lazaro CG, Blum MJ. The Relationship Between Patients’ Satisfaction With Their Physicians and Perceptions About Interventions They Desired and Received. Medical Care. 1989 Nov;27(11):1027–35. DOI: 10.1097/00005650-198911000-00004
200. Sanchez-Menegay C, Hudes ES, Cummings SR. Patient expectations and satisfaction with medical care for upper respiratory infections. Journal of General Internal Medicine. 1992 Aug;7(4):432–4. DOI: 10.1007/BF02599162
201. Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine. 2014 Apr;32(19):2150–9. DOI: 10.1016/j.vaccine.2014.01.081
202. Greenhalgh T. ‘Health for me’: a sociocultural analysis of healthism in the middle classes. British Medical Bulletin. 2004 Dec 1;69(1):197–213. DOI: 10.1093/bmb/ldh013
203. Gale N. The Sociology of Traditional, Complementary and Alternative Medicine: Traditional, Complementary and Alternative Medicine. Sociology Compass. 2014 Jun;8(6):805–22. DOI: 10.1111/soc4.12182
204. Fine P, Eames K, Heymann DL. ‘Herd Immunity’: A Rough Guide. Clinical Infectious Diseases. 2011 Apr 1;52(7):911–6. DOI: 10.1093/cid/cir007
205. Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015 Dec;13(1):146. DOI: 10.1186/s12916-015-0382-8
206. Havers FP, Moro PL, Hariri S, Skoff T. Pinkbook: Pertussis. Centers for Disease Control and Prevention [Internet]. 2020 Dec [cited 2021 Jun 1]; Available from: https://www.cdc.gov/vaccines/pubs/pinkbook/pert.html
207. Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019. MMWR Morbidity and Mortality Weekly Report. 2020 Jan 24;69(3):77–83. DOI: 10.15585/mmwr.mm6903a5
208. Rabe S. impf-info.de. Beiträge zu einer differenzierten Impfentscheidung. Übersicht Herdenimmunität im Kindesalter [Internet]. impf-info.de. 2021 [cited 2021 Apr 14]. Available from: https://www.impf-info.de/neben-wirkungen/wirkungen/205-herdenimmunit%C3%A4t.html
209. Committee to Review Adverse Effects of Vaccines; Institute of Medicine (U.S.); Stratton KR, editors. Adverse effects of vaccines: evidence and causality. Washington (DC): National Academies Press (US); 2012. 865 p. DOI: 10.17226/13164
210. Maglione MA, Das L, Raaen L, Smith A, Chari R, Newberry S, et al. Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review. Pediatrics. 2014 Aug 1;134(2):325–37. DOI: 10.1542/peds.2014-1079
211. Byington CL. Vaccines: Can Transparency Increase Confidence and Reduce Hesitancy? Pediatrics. 2014 Aug 1;134(2):377–9. DOI: 10.1542/peds.2014-1494
212. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies [Internet]. Washington, D.C.: National Academies Press; 2013 [cited 2021 Apr 11]. Available from: http://www.nap.edu/catalog/13563
213. Westra J, Rondaan C, van Assen S, Bijl M. Vaccination of patients with autoimmune inflammatory rheumatic diseases. Nature Reviews Rheumatology. 2015 Mar;11(3):135–45. DOI: 10.1038/nrrheum.2014.206
214. Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cellular & Molecular Immunology. 2018 Jun;15(6):586–94. DOI: 10.1038/cmi.2017.151
215. Bonetto C, Trotta F, Felicetti P, Alarcón GS, Santuccio C, Bachtiar NS, et al. Vasculitis as an adverse event following immunization – Systematic literature review. Vaccine. 2016 Dec;34(51):6641–51. DOI: 10.1016/j.vaccine.2015.09.026
216. Heininger U, Holm K, Caplanusi I, Bailey SR, Asfijah Abdoellah S, Arellano F, et al. Guide to active vaccine safety surveillance: Report of CIOMS working group on vaccine safety – executive summary. Vaccine. 2017 Jul;35(32):3917–21. DOI: 10.1016/j.vaccine.2017.06.033
217. Lei J, Balakrishnan MR, Gidudu JF, Zuber PLF. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015. Vaccine. 2018 Mar;36(12):1577–82. DOI: 10.1016/j.vaccine.2018.02.012
218. DeStefano F, Bodenstab HM, Offit PA. Principal Controversies in Vaccine Safety in the United States. Clinical Infectious Diseases. 2019 Aug 1;69(4):726–31. DOI: 10.1093/cid/ciz135
219. Di Pasquale A, Bonanni P, Garçon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Vaccine safety evaluation: Practical aspects in assessing benefits and risks. Vaccine. 2016 Dec;34(52):6672–80. DOI: 10.1016/j.vaccine.2016.10.039
220. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental Vaccine Safety Concerns in 2009. Pediatrics. 2010 Apr 1;125(4):654–9. DOI: 10.1542/peds.2009-1962
221. Ameratunga R, Langguth D, Hawkes D. Perspective: Scientific and ethical concerns pertaining to animal models of autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). Autoimmunity Reviews. 2018 May;17(5):435–9. DOI: 10.1016/j.autrev.2017.11.033
222. Bascaron ME, Parrat D. Le médecin face aux mythes sur la vaccination. Revue Médicale Suisse [Internet]. 2017 Sep 27 [cited 2021 Apr 13]. Available from: https://www.revmed.ch/revue-medicale-suisse/2017/revue-medicale-suisse-576/le-medecin-face-aux-mythes-sur-la-vaccination#tab=tab-read
223. Baxter R, Bakshi N, Fireman B, Lewis E, Ray P, Vellozzi C, et al. Lack of Association of Guillain-Barré Syndrome With Vaccinations. Clinical Infectious Diseases. 2013 Apr 11;57(2):197–204. DOI: 10.1093/cid/cit222
224. Baxter R, Lewis E, Fireman B, DeStefano F, Gee J, Klein NP. Case-centered Analysis of Optic Neuritis After Vaccines. Clinical Infectious Diseases. 2016 Apr 10;63(1):79–81. DOI: 10.1093/cid/ciw224
225. Salmon DA, Halsey NA. Guillain-Barré Syndrome and Vaccinations. Clinical Infectious Diseases. 2013 Apr 11;57(2):205–7. DOI: 10.1093/cid/cit218
226. Panozzo CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, Woerner A, Bonhoeffer J. Arthritis and arthralgia as an adverse event following immunization: A systematic literature review. Vaccine. 2019 Jan;37(2):372–83. DOI: 10.1016/j.vaccine.2018.06.067
227. Karafillakis E, Larson HJ. The paradox of vaccine hesitancy among healthcare professionals. Clinical Microbiology and Infection. 2018 Aug;24(8):799–800. DOI: 10.1016/j.cmi.2018.04.001
228. Armstrong D. Actors, patients and agency: a recent history. Sociology of Health & Illness. 2014 Feb;36(2):163–74. DOI: 10.1111/1467-9566.12100
229. FMH Zentralvorstand / Comité central de la FMH. Die Position der FMH. «Choosing Wisely»: Weniger Leistungen für mehr Nutzen. Schweizerische Ärztezeitung. 2017 Jan 31;98(05):144–5. DOI: 10.4414/saez.2017.05276
230. Vincent C, Staines A. Verbesserung der Qualität und Patientensicherheit des schweizerischen Gesundheitswesens. Bundesamt für Gesundheit [Internet]. 2019 Jun 30 [cited 2021 Apr 18]; Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/cc/kom/Qualitaetsbericht.pdf.download.pdf/Qualit%C3%A4tsbericht.pdf
231. Michaud PA, Jucker-Kupper P, members of the Profiles Working Group. Principal Objectives and Framework for Integrated Learning and Education in Switzerland. Profiles [Internet]. 2017 [cited 2021 Apr 18]; Available from: http://www.profilesmed.ch/doc/Profiles_2017.pdf
232. Légaré F, Adekpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, et al. Interventions for increasing the use of shared decision making by healthcare professionals. Cochrane Effective Practice and Organisation of Care Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2018 Jul 19 [cited 2021 Apr 18]; Available from: http://doi.wiley.com/10.1002/14651858.CD006732.pub4
233. Kienlin S, Nytrøen K, Stacey D, Kasper J. Ready for shared decision making: Pretesting a training module for health professionals on sharing decisions with their patients. Journal of Evaluation in Clinical Practice. 2020 Apr;26(2):610–21. DOI: 10.1111/jep.13380
234. Rosca A, Krones T, Biller-Andorno N. Shared decision making: patients have a right to be informed about possible treatment options and their risks and benefits. Swiss Medical Weekly [Internet]. 2020 Jul 6 [cited 2021 Apr 11]; Available from: https://doi.emh.ch/smw.2020.20268
235. Bundesamt für Gesundheit BAG. Das neue Epidemiengesetz [Internet]. 2013 [cited 2021 Apr 17]. Available from: https://www.bag.admin.ch/dam/bag/de/dokumente/mt/epidemiengesetz/factsheet-epg-lep.pdf.download.pdf/Factsheet%20EpG_d.pdf